.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Cerilliant
Fuji
Accenture
Mallinckrodt
Farmers Insurance
Merck
Chinese Patent Office
Citi

Generated: November 17, 2017

DrugPatentWatch Database Preview

MELPHALAN HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Melphalan Hydrochloride, and when can generic versions of Melphalan Hydrochloride launch?

Melphalan Hydrochloride is a drug marketed by West-ward Pharms Int, Actavis Llc, Mylan Institutional, Par Sterile Products, and Sagent Pharms. and is included in six NDAs.

The generic ingredient in MELPHALAN HYDROCHLORIDE is melphalan hydrochloride. There are twelve drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the melphalan hydrochloride profile page.

Pharmacology for MELPHALAN HYDROCHLORIDE

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION090303-001Oct 28, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Par Sterile Products
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION204773-001Aug 22, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION206018-001Dec 19, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION090270-001Jun 9, 2009APRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Institutional
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION090299-001Oct 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Sagent Pharms
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION201379-001Feb 28, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Covington
Moodys
Teva
Argus Health
UBS
McKesson
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot